✦ LIBER ✦

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

✍ Scribed by Jackson, Graham H.; Morgan, Gareth J.; Davies, Faith E.; Wu, Ping; Gregory, Walter M.; Bell, Sue E.; Szubert, Alexander J.; Navarro Coy, Nuria; Drayson, Mark T.; Owen, Roger G.; Feyler, Sylvia; Ashcroft, Andrew J.; Ross, Fiona M.; Byrne, Jennifer; Roddie, Huw; Rudin, Claudius; Boyd, Kevin D.; Osborne, Wendy L.; Cook, Gordon; Child, J. Anthony

Book ID: 121747365
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 158 KB
Volume: 166
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12861

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the Medical Research Council

Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)

✍ G.J. Morgan*; F.E. Davies; W.M. Gregory; S.E. Bell; A.J. Szubert; N. Navarro Coy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 72 KB

The Medical Research Council Myeloma IX

The Medical Research Council Myeloma IX Trial: New Clinical Insights on the Anticancer Effects of Zoledronic Acid in Patients With Multiple Myeloma

✍ James R. Berenson 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 169 KB

COMPARE - Results of a randomised study

COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients

✍ Raoul Bergner; Hartmut Goldschmidt; Martin Kropff; Wolfram Pönisch; Claudia Kiew 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Health-related quality of life in elderl

✍ Michel Delforge; Ravinder Dhawan; Don Robinson Jr; Juliette Meunier; Antoine Reg 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

Bortezomib Induction and Maintenance Tre

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

✍ Sonneveld, P.; Schmidt-Wolf, I. G. H.; van der Holt, B.; el Jarari, L.; Bertsch, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 232 KB

Risk factors for, and reversibility of,

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib–melphalan–prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

✍ Meletios A. Dimopoulos; Maria-Victoria Mateos; Paul G. Richardson; Rudolf Schlag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB